// App-Quantinova.ai

AB0681 (2021) : HOW COMMON IS COVID-19 IN CHILDREN, YOUNG PEOPLE AND ADULTS WITH RHEUMATIC DISEASES? RESULTS FROM THE INTERNATIONAL COVID-19 EUROPEAN PATIENT REGISTRY

Researchers

Presenter

  • S. Shoop-Worrall

Principal Investigators

  • S. Verstappen

  • W. Costello

  • S. Angevare

  • Y. Uziel

  • C. Wouters

  • N. Wulffraat

  • R. Beesley

Medical Centers

  • The University of Manchester, Centre for Health Infomatics, Manchester, United Kingdom

  • The University of Manchester, Centre for Epidemiology Versus Arthritis, M13 9PT, United Kingdom

  • Manchester University NHS FT, Manchester Academic Health Science Centre, Manchester, United Kingdom, Manchester, England, United Kingdom

  • ENCA, European Network for Children with Arthritis, Geneva, Switzerland

  • iCAN, iCAN Ireland, Bansha, Ireland

  • KAISZ, KAISZ, Amsterndam, Netherlands

  • Meir Medical Center, Rheumatology Unit, Kefar Sava, Israel

  • Sackler School of Medicine, Department of Neurology, Tel Aviv, Israel

  • University Hospitals Leuven, Pediatric Rheumatology Division, Leuven, Belgium

  • KU Leuven, Department of Microbiology and Immunology, Leuven, Belgium

  • Wilhelmina Children’s Hospital (WKZ), Department of Pediatric Rheumatology, Utrecht, Netherlands

  • Juvenile Arthritis Research, Juvenile Arthritis Research, Tonbridge, United Kingdom

Locations

  • United Kingdom

  • Switzerland

  • Ireland

  • Netherlands

  • Israel

  • Belgium

Companies

  • N/A

Study Components

Therapeutic Area

  • Infectious Diseases (ID)

Disease

  • Coronavirus disease

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Multinational

  • Prospective

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • Abbvie

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved